Literature DB >> 26260197

[Perioperative treatment of patients with long QT syndrome].

T Krönauer1, P Friederich.   

Abstract

Long QT syndrome (LQTS) is caused by a change in cardiac repolarization due to functional ion channel dysfunction which is associated with an elongation of the QT interval (hence the name) in the electrocardiogram and a predisposition to cardiac rhythm disorders (e.g. torsade de pointes, TdP) as well as cardiac events up to sudden cardiac death. There is a congenital (cLQTS) and an acquired (aLQTS) form of the disease. The prevalence of cLQTS is 1 in 2000 but aLQTS is much more common and includes a grey area due to many asymptomatic patients. The LQTS is, therefore, more common than malignant hyperthermia which is much discussed in anesthesiology and has a reported prevalence in the population of 1:3000. Considering the prevalence of both aLQTS as well as cLQTS the importance of the LQTS seems to be underestimated in current perioperative care. Potential perioperative risks of such patients can be significantly reduced by appropriate patient management. This includes adequate preoperative preparation, the correct choice of anesthetic medication as well as adequate perioperative monitoring and preparedness for immediate pharmaceutical and electrical intervention in case of typical cardiac rhythm disturbances, such as TdP arrhythmia.

Entities:  

Mesh:

Year:  2015        PMID: 26260197     DOI: 10.1007/s00101-015-0067-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  62 in total

1.  Automated perioperative QT monitoring in a patient with long QT syndrome 2.

Authors:  D Anton; P Friederich
Journal:  Br J Anaesth       Date:  2010-11       Impact factor: 9.166

2.  The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children.

Authors:  Simon D Whyte; Peter D Booker; David G Buckley
Journal:  Anesth Analg       Date:  2005-01       Impact factor: 5.108

3.  Intraoperative cardiac arrest in acquired long QT syndrome.

Authors:  S Dolenska
Journal:  Br J Anaesth       Date:  2009-04       Impact factor: 9.166

4.  Intraoperative torsade de pointes ventricular tachycardia and ventricular fibrillation during sevoflurane anesthesia.

Authors:  K Abe; K Takada; I Yoshiya
Journal:  Anesth Analg       Date:  1998-04       Impact factor: 5.108

5.  Long QT syndrome: anaesthetic management at delivery.

Authors:  S Behl; T D Wauchob
Journal:  Int J Obstet Anesth       Date:  2005-10       Impact factor: 2.603

6.  Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome.

Authors:  Michael J Ackerman; Anant Khositseth; David J Tester; Joseph B Hejlik; Win-Kuang Shen; Co-burn J Porter
Journal:  Mayo Clin Proc       Date:  2002-05       Impact factor: 7.616

7.  QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease.

Authors:  Gi Beom Kim; Hee Yeon Cho; Bo Sang Kwon; Eun Jung Bae; Chung Il Noh; Jung Yeon Choi; Yong Soo Yun; Yong Choi; Jong Won Ha
Journal:  Int J Cardiol       Date:  2007-08-21       Impact factor: 4.164

8.  Local anaesthetic sensitivities of cloned HERG channels from human heart: comparison with HERG/MiRP1 and HERG/MiRP1 T8A.

Authors:  P Friederich; A Solth; S Schillemeit; D Isbrandt
Journal:  Br J Anaesth       Date:  2004-01       Impact factor: 9.166

9.  Dolasetron-induced torsades de pointes.

Authors:  Sarah Turner; Letha Mathews; Pratik Pandharipande; Reid Thompson
Journal:  J Clin Anesth       Date:  2007-12       Impact factor: 9.452

10.  Long QT syndrome provoked by induction of general anesthesia -A case report-.

Authors:  Hyung Tae Kim; Jun Hak Lee; Il Bong Park; Hyeon Eon Heo; Tae Yoon Kim; Myeong Jong Lee
Journal:  Korean J Anesthesiol       Date:  2010-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.